{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:58:19Z","timestamp":1791838699985,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004344","name":"Stichting Astma Bestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004344","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.rmed.2026.108737","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:11:28Z","timestamp":1772125888000},"page":"108737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gut integrity, systemic inflammation and exacerbations of COPD: the role of I-FABP"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7449-4408","authenticated-orcid":false,"given":"Daphne E.M.","family":"Peerlings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy T.M.","family":"Sprooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel F.M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-0538","authenticated-orcid":false,"given":"Kaatje","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki L.","family":"Reynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam T.J.","family":"Groenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Houben-Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami O.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-6356","authenticated-orcid":false,"given":"Frits M.E.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.108737_bib1","series-title":"Diagnosis and Management of COPD: 2025 Report","article-title":"Global strategy for prevention","year":"2025"},{"issue":"2","key":"10.1016\/j.rmed.2026.108737_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/ijabmr.IJABMR_258_17","article-title":"Correlation of severity of functional gastrointestinal disease symptoms with that of asthma and chronic obstructive pulmonary disease: a multicenter study","volume":"8","author":"Ojha","year":"2018","journal-title":"Int J Appl Basic Med Res."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00203-024-03843-6","article-title":"A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases","volume":"206","author":"Xu","year":"2024","journal-title":"Arch. Microbiol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mi.2011.55","article-title":"Pulmonary-intestinal cross-talk in mucosal inflammatory disease","volume":"5","author":"Keely","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut-lung axis","volume":"15","author":"Budden","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.rmed.2026.108737_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1164\/rccm.202206-1066TR","article-title":"The bidirectional gut-lung axis in chronic obstructive pulmonary disease","volume":"207","author":"Wang","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108737_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1378\/chest.13-2077","article-title":"Lung-gut cross talk: a potential mechanism for intestinal dysfunction in patients with COPD","volume":"145","author":"Keely","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2026.108737_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1378\/chest.13-0584","article-title":"Disturbed intestinal integrity in patients with COPD: effects of activities of daily living","volume":"145","author":"Rutten","year":"2014","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rmed.2026.108737_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30612","article-title":"The role of gut-lung axis in COPD: pathogenesis, immune response, and prospective treatment","volume":"10","author":"Song","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.rmed.2026.108737_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249944","article-title":"Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity","volume":"16","author":"Chiu","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-022-01928-8","article-title":"Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study","volume":"23","author":"Chiu","year":"2022","journal-title":"Respir. Res."},{"issue":"11","key":"10.1016\/j.rmed.2026.108737_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MCG.0b013e3182a87e3e","article-title":"Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model","volume":"48","author":"Schellekens","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"issue":"7","key":"10.1016\/j.rmed.2026.108737_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9120(03)00096-1","article-title":"Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility","volume":"36","author":"Pelsers","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.rmed.2026.108737_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101178","article-title":"Intestinal fatty acid binding protein: a rising therapeutic target in lipid metabolism","volume":"87","author":"Huang","year":"2022","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.rmed.2026.108737_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000485935","article-title":"Increased small intestinal permeability during severe acute exacerbations of COPD","volume":"95","author":"Sprooten","year":"2018","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.rmed.2026.108737_bib18","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.clnu.2020.10.010","article-title":"Intestinal function is impaired in patients with chronic obstructive pulmonary disease","volume":"40","author":"Kirschner","year":"2021","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1016\/j.rmed.2026.108737_bib19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.21037\/apm-20-1060","article-title":"Screening for and combining serum intestinal barrier-related biomarkers to predict the disease severity of AECOPD","volume":"10","author":"Yin","year":"2020","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1378\/chest.15-0645","article-title":"Various mechanistic pathways representing the aging process are altered in COPD","volume":"149","author":"Rutten","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2026.108737_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8040511","article-title":"Disease-specific comorbidity clusters in COPD and accelerated aging","volume":"8","author":"Triest","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108737_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108737_bib23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1249\/MSS.0b013e318265dd3d","article-title":"Aggravation of exercise-induced intestinal injury by ibuprofen in athletes","volume":"44","author":"Van Wijck","year":"2012","journal-title":"Med. Sci. Sports Exerc."},{"issue":"1-2","key":"10.1016\/j.rmed.2026.108737_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1020520521025","article-title":"Intracellular lipid binding proteins of the small intestine","volume":"239","author":"Agellon","year":"2002","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.rmed.2026.108737_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.rmed.2026.108737_bib26","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","article-title":"Additional value of serum I-FABP levels for evaluating celiac disease activity in children","volume":"46","author":"Vreugdenhil","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.rmed.2026.108737_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12986-016-0089-7","article-title":"The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity","volume":"13","author":"Lau","year":"2016","journal-title":"Nutr. Metab."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108737_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.868086","article-title":"COPD and gut\u2013lung axis: how microbiota and host inflammasome influence COPD and related therapeutics","volume":"13","author":"Qu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rmed.2026.108737_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2021.09.051","article-title":"Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection","volume":"113","author":"Saia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.rmed.2026.108737_bib31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib32","article-title":"Effect sizes for nonparametric tests","volume":"36","author":"Fiel","year":"2026","journal-title":"Biochem. Med."},{"key":"10.1016\/j.rmed.2026.108737_bib33","article-title":"Inflammation mechanism and research progress of COPD","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2026.108737_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10121029","article-title":"Combination of systemic inflammatory biomarkers in assessment of chronic obstructive pulmonary disease: diagnostic performance and identification of networks and clusters","volume":"10","author":"Hlap\u010di\u0107","year":"2020","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib35","first-page":"311","article-title":"Exploring the role of gut-lung interactions in COPD pathogenesis: a comprehensive review on microbiota characteristics and inflammation modulation","volume":"11","author":"Cheng","year":"2024","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"11","key":"10.1016\/j.rmed.2026.108737_bib36","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.108737_bib37","first-page":"759","article-title":"Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease","volume":"9","author":"Bade","year":"2014","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2026.108737_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00408-008-9106-6","article-title":"Biomarkers of systemic inflammation in stable and exacerbation phases of COPD","volume":"186","author":"Karadag","year":"2008","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2026.108737_bib39","series-title":"Lung Cytokines and Systemic Inflammation in Patients with COPD","author":"Morello Gearhart","year":"2017"},{"key":"10.1016\/j.rmed.2026.108737_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619866096","article-title":"Association between tumor necrosis factor-\u03b1 and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"13","author":"Yao","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2026.108737_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"Agust\u00ed","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1465-9921-14-24","article-title":"Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease","volume":"14","author":"Ferrari","year":"2013","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib43","first-page":"13","article-title":"The significance of serum Interleukin-8 in acute exacerbations of chronic obstructive pulmonary disease","volume":"17","author":"Zhang","year":"2018","journal-title":"Tanaffos"},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1465-9921-4-11","article-title":"Circulating monocytes from healthy individuals and COPD patients","volume":"4","author":"Aldonyte","year":"2003","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.rmed.2026.108737_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3906\/sag-1909-9","article-title":"Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD","volume":"50","author":"Aslani","year":"2020","journal-title":"Turk. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.rmed.2026.108737_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115242","article-title":"I-FABP as biomarker for the early diagnosis of acute mesenteric ischemia and resultant lung injury","volume":"9","author":"Khadaroo","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.rmed.2026.108737_bib47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2026.108737_bib48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2362.2012.02646.x","article-title":"Decreased plasma sRAGE levels in COPD: influence of oxygen therapy","volume":"42","author":"Gopal","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.rmed.2026.108737_bib49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.201302-0247OC","article-title":"Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease","volume":"188","author":"Cheng","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MS9.0000000000000264","article-title":"APACHE scoring as an indicator of mortality rate in ICU patients: a cohort study","volume":"85","author":"Mumtaz","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.rmed.2026.108737_bib51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejvsvf.2024.04.004","article-title":"Intestinal fatty acid binding protein as a predictor of early mesenteric injury preceding clinical presentation: a case report","volume":"61","author":"Duivenvoorden","year":"2024","journal-title":"EJVES Vascular Forum"},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1249\/MSS.0000000000001800","article-title":"Sucrose but not nitrate ingestion reduces strenuous cycling\u2013induced intestinal injury","volume":"51","author":"Jonvik","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"issue":"10","key":"10.1016\/j.rmed.2026.108737_bib53","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00268-007-9182-4","article-title":"Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection","volume":"31","author":"van de Poll","year":"2007","journal-title":"World J. Surg."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5114\/ait.2019.86049","article-title":"Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill","volume":"51","author":"Blaser","year":"2019","journal-title":"Anaesthesiol. Intensive Ther."},{"issue":"131","key":"10.1016\/j.rmed.2026.108737_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1183\/09059180.00007613","article-title":"Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?","volume":"23","author":"Franssen","year":"2014","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2026.108737_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1513\/pats.200709-148ET","article-title":"Comorbidities in chronic obstructive pulmonary disease","volume":"5","author":"Chatila","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.rmed.2026.108737_bib57","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1378\/chest.14-0285","article-title":"GI symptoms in patients with COPD","volume":"145","author":"Rutten","year":"2014","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rmed.2026.108737_bib58","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/resp.14100","article-title":"Longitudinal changes in total and regional body composition in patients with chronic obstructive pulmonary disease","volume":"26","author":"Machado","year":"2021","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.rmed.2026.108737_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern. Emerg. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000447252","article-title":"Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation?","volume":"1","author":"Fukui","year":"2016","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.rmed.2026.108737_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1160030","article-title":"Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure","volume":"10","author":"Nendl","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.108737_bib62","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/gutjnl-2022-327365","article-title":"A mechanism by which gut microbiota elevates permeability and inflammation in obese\/diabetic mice and human gut","volume":"72","author":"Mishra","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10238-024-01496-9","article-title":"Intestinal permeability disturbances: causes, diseases and therapy","volume":"24","author":"Macura","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.rmed.2026.108737_bib64","article-title":"The associations between gut microbiota and chronic respiratory diseases: a Mendelian randomization study","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rmed.2026.108737_bib65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2147\/COPD.S441242","article-title":"Genetic insights into the gut-lung axis: mendelian randomization analysis on gut microbiota, lung function, and COPD","volume":"19","author":"Cheng","year":"2024","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94040","article-title":"Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction","volume":"3","author":"Fricker","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.rmed.2026.108737_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1380713","article-title":"Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise","volume":"15","author":"Dmytriv","year":"2024","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.rmed.2026.108737_bib68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1183\/09031936.04.00012704","article-title":"The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation","volume":"23","author":"Willemse","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib69","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2519699","article-title":"Intestinal host-microbe interactions fuel pulmonary inflammation in cigarette smoke exposed mice","volume":"17","author":"Yang-Jensen","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.rmed.2026.108737_bib70","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3389\/fimmu.2019.02289","article-title":"Mucosal exposure to cigarette components induces intestinal inflammation and alters antimicrobial response in mice","volume":"10","author":"Berkowitz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2026.108737_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.673341","article-title":"Effect of cigarette smoke on gut microbiota: state of knowledge","volume":"12","author":"Gui","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/bja\/77.1.50","article-title":"Determinants of splanchnic blood flow","volume":"77","author":"Takala","year":"1996","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"10.1016\/j.rmed.2026.108737_bib73","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2353\/ajpath.2010.091069","article-title":"Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model","volume":"176","author":"Grootjans","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.rmed.2026.108737_bib74","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1152\/japplphysiol.00085.2009","article-title":"Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity","volume":"106","author":"Rodr\u00edguez-Roisin","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2026.108737_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/14799731211056340","article-title":"Diffusing capacity in chronic obstructive pulmonary disease assessment: a meta-analysis","volume":"18","author":"Ni","year":"2021","journal-title":"Chron. Respir. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.108737_bib76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0974-1208.97779","article-title":"Sample size estimation and power analysis for clinical research studies","volume":"5","author":"Suresh","year":"2012","journal-title":"J. Hum. Reprod. Sci."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:22:21Z","timestamp":1775305341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":75,"alternative-id":["S0954611126001058"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108737","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut integrity, systemic inflammation and exacerbations of COPD: the role of I-FABP","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108737"}}